InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by McMurdo Matthew Charles. Director active across 3 companies, notably Titan Pharmaceuticals INC. Aggregated, 6 disclosures have been logged. Activity tracked since 26 July 2023. The latest transaction was filed on 25 October 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
McMurdo Matthew Charles is a declarant linked to Titan Pharmaceuticals INC, MINIM, INC. and OPGEN INC, where he is a Director. He has 6 filings in total, and the 6 sampled filings run from 2023-07-28 to 2024-10-01; the modal transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.